Abbott's MitraClip Approved as First Transcatheter Mitral Valve Repair Device in Japan

First minimally invasive device to treat people in Japan with common leaky heart valve for whom surgery is too risky More than 50,000 patients worldwide have been treated with the MitraClip therapy ABBOTT PARK, Ill., Nov. 6, 2017 -- (Healthcare Sales... Devices, Interventional, Cardiology, Regulatory Abbott, MitraClip, Mitral Valve Repair, mitral regurgitation
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news